nci h660 Search Results


ncih660  (ATCC)
97
ATCC ncih660
Ncih660, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nci+h660/pm41162153-233-14-25?v=ATCC
Average 97 stars, based on 1 article reviews
ncih660 - by Bioz Stars, 2026-07
97/100 stars
  Buy from Supplier
ne-like cells (pc3, du145, nci-h660), lncap, c4-2 cells  (ScienCell)
90
ScienCell ne-like cells (pc3, du145, nci-h660), lncap, c4-2 cells
PCAT6 expression was increased in NEPC cells and tissues. (A) qPCR analysis of the top 10 lncRNAs (PCAT6, LncRNA7816-1, LncRNA2323-2, LINC00319, lncRNA-p21, Malat1, PCA3, LncRNA8802, LncRNA1698-1 and LncRNA2303) mRNA expression in NCI-H660 cells and <t>LNCaP</t> cells. (B) qPCR analysis of PCAT6 mRNA expression in NE-like <t>cells</t> <t>(PC3,</t> DU145, and NCI-H660) and LNCaP and C4-2 cells. (C, D) The mRNA expression of PCAT6 was determined in LNCaP cells treated with different Enza concentration (2 μM, 4 μM, 8 μM, 10 μM) for 72 h or 10 μM for different times (0 h, 12 h, 24 h, 48 h, 72 h). (E) Fluorescent in situ hybridization (FISH) assay of the PCAT6 expression in LNCaP and NCI-H660 cells. (F) Fluorescent in situ hybridization (FISH) assay of the PCAT6 expression in LNCaP cells with 10 μM Enza treatment for 72 h. (G) qPCR analysis of PCAT6 expression in Pca tissues and adjacent normal tissues. (H) qPCR analysis of PCAT6 expression in NEPC (n=9) and CRPC (n=18) samples. * p <0.05. ** p <0.01.
Ne Like Cells (Pc3, Du145, Nci H660), Lncap, C4 2 Cells, supplied by ScienCell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nci+h660/pmc08278330-35-6-12?v=ScienCell
Average 90 stars, based on 1 article reviews
ne-like cells (pc3, du145, nci-h660), lncap, c4-2 cells - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
nci-h660  (Corning Life Sciences)
90
Corning Life Sciences nci-h660
PCAT6 expression was increased in NEPC cells and tissues. (A) qPCR analysis of the top 10 lncRNAs (PCAT6, LncRNA7816-1, LncRNA2323-2, LINC00319, lncRNA-p21, Malat1, PCA3, LncRNA8802, LncRNA1698-1 and LncRNA2303) mRNA expression in NCI-H660 cells and <t>LNCaP</t> cells. (B) qPCR analysis of PCAT6 mRNA expression in NE-like <t>cells</t> <t>(PC3,</t> DU145, and NCI-H660) and LNCaP and C4-2 cells. (C, D) The mRNA expression of PCAT6 was determined in LNCaP cells treated with different Enza concentration (2 μM, 4 μM, 8 μM, 10 μM) for 72 h or 10 μM for different times (0 h, 12 h, 24 h, 48 h, 72 h). (E) Fluorescent in situ hybridization (FISH) assay of the PCAT6 expression in LNCaP and NCI-H660 cells. (F) Fluorescent in situ hybridization (FISH) assay of the PCAT6 expression in LNCaP cells with 10 μM Enza treatment for 72 h. (G) qPCR analysis of PCAT6 expression in Pca tissues and adjacent normal tissues. (H) qPCR analysis of PCAT6 expression in NEPC (n=9) and CRPC (n=18) samples. * p <0.05. ** p <0.01.
Nci H660, supplied by Corning Life Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nci+h660/pm15364128-75-3-19?v=Corning+Life+Sciences
Average 90 stars, based on 1 article reviews
nci-h660 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
nci-h660  (China Center for Type Culture Collection)
90
China Center for Type Culture Collection nci-h660
PCAT6 expression was increased in NEPC cells and tissues. (A) qPCR analysis of the top 10 lncRNAs (PCAT6, LncRNA7816-1, LncRNA2323-2, LINC00319, lncRNA-p21, Malat1, PCA3, LncRNA8802, LncRNA1698-1 and LncRNA2303) mRNA expression in NCI-H660 cells and <t>LNCaP</t> cells. (B) qPCR analysis of PCAT6 mRNA expression in NE-like <t>cells</t> <t>(PC3,</t> DU145, and NCI-H660) and LNCaP and C4-2 cells. (C, D) The mRNA expression of PCAT6 was determined in LNCaP cells treated with different Enza concentration (2 μM, 4 μM, 8 μM, 10 μM) for 72 h or 10 μM for different times (0 h, 12 h, 24 h, 48 h, 72 h). (E) Fluorescent in situ hybridization (FISH) assay of the PCAT6 expression in LNCaP and NCI-H660 cells. (F) Fluorescent in situ hybridization (FISH) assay of the PCAT6 expression in LNCaP cells with 10 μM Enza treatment for 72 h. (G) qPCR analysis of PCAT6 expression in Pca tissues and adjacent normal tissues. (H) qPCR analysis of PCAT6 expression in NEPC (n=9) and CRPC (n=18) samples. * p <0.05. ** p <0.01.
Nci H660, supplied by China Center for Type Culture Collection, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nci+h660/pm28624527-46-22-38?v=China+Center+for+Type+Culture+Collection
Average 90 stars, based on 1 article reviews
nci-h660 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

Image Search Results


PCAT6 expression was increased in NEPC cells and tissues. (A) qPCR analysis of the top 10 lncRNAs (PCAT6, LncRNA7816-1, LncRNA2323-2, LINC00319, lncRNA-p21, Malat1, PCA3, LncRNA8802, LncRNA1698-1 and LncRNA2303) mRNA expression in NCI-H660 cells and LNCaP cells. (B) qPCR analysis of PCAT6 mRNA expression in NE-like cells (PC3, DU145, and NCI-H660) and LNCaP and C4-2 cells. (C, D) The mRNA expression of PCAT6 was determined in LNCaP cells treated with different Enza concentration (2 μM, 4 μM, 8 μM, 10 μM) for 72 h or 10 μM for different times (0 h, 12 h, 24 h, 48 h, 72 h). (E) Fluorescent in situ hybridization (FISH) assay of the PCAT6 expression in LNCaP and NCI-H660 cells. (F) Fluorescent in situ hybridization (FISH) assay of the PCAT6 expression in LNCaP cells with 10 μM Enza treatment for 72 h. (G) qPCR analysis of PCAT6 expression in Pca tissues and adjacent normal tissues. (H) qPCR analysis of PCAT6 expression in NEPC (n=9) and CRPC (n=18) samples. * p <0.05. ** p <0.01.

Journal: Frontiers in Oncology

Article Title: Enzalutamide-Induced Upregulation of PCAT6 Promotes Prostate Cancer Neuroendocrine Differentiation by Regulating miR-326/HNRNPA2B1 Axis

doi: 10.3389/fonc.2021.650054

Figure Lengend Snippet: PCAT6 expression was increased in NEPC cells and tissues. (A) qPCR analysis of the top 10 lncRNAs (PCAT6, LncRNA7816-1, LncRNA2323-2, LINC00319, lncRNA-p21, Malat1, PCA3, LncRNA8802, LncRNA1698-1 and LncRNA2303) mRNA expression in NCI-H660 cells and LNCaP cells. (B) qPCR analysis of PCAT6 mRNA expression in NE-like cells (PC3, DU145, and NCI-H660) and LNCaP and C4-2 cells. (C, D) The mRNA expression of PCAT6 was determined in LNCaP cells treated with different Enza concentration (2 μM, 4 μM, 8 μM, 10 μM) for 72 h or 10 μM for different times (0 h, 12 h, 24 h, 48 h, 72 h). (E) Fluorescent in situ hybridization (FISH) assay of the PCAT6 expression in LNCaP and NCI-H660 cells. (F) Fluorescent in situ hybridization (FISH) assay of the PCAT6 expression in LNCaP cells with 10 μM Enza treatment for 72 h. (G) qPCR analysis of PCAT6 expression in Pca tissues and adjacent normal tissues. (H) qPCR analysis of PCAT6 expression in NEPC (n=9) and CRPC (n=18) samples. * p <0.05. ** p <0.01.

Article Snippet: NE-like cells (PC3, DU145, and NCI-H660), LNCaP, C4-2 cells were purchased from ScienCell (Santiago, California, USA).

Techniques: Expressing, Concentration Assay, In Situ Hybridization

PCAT6 promoted NED, proliferation, and invasion of PCa cells in vitro . (A) qPCR analysis of NE markers (NSE, SYP, and ChgA) mRNA expression in LNCaP cells after PCAT6 overexpression. (B, C) Western blot analysis for NSE, SYP, and ChgA protein level in LNCaP cells after PCAT6 overexpression. (D) qPCR analysis of NSE, SYP, and ChgA mRNA expression in NCI-H660 cells after PCAT6 knockdown. (E) LNCaP cell proliferation was assayed using CCK-8 after PCAT6 overexpression. (F) NCI-H660 cell proliferation was assayed using CCK-8 after PCAT6 knockdown. (G, H) LNCaP cell invasion was assessed using transwell invasion assay after PCAT6 overexpression. (I, J) NCI-H660 cell invasion was assessed using transwell invasion assay after PCAT6 knockdown. * p <0.05. ** p <0.01.

Journal: Frontiers in Oncology

Article Title: Enzalutamide-Induced Upregulation of PCAT6 Promotes Prostate Cancer Neuroendocrine Differentiation by Regulating miR-326/HNRNPA2B1 Axis

doi: 10.3389/fonc.2021.650054

Figure Lengend Snippet: PCAT6 promoted NED, proliferation, and invasion of PCa cells in vitro . (A) qPCR analysis of NE markers (NSE, SYP, and ChgA) mRNA expression in LNCaP cells after PCAT6 overexpression. (B, C) Western blot analysis for NSE, SYP, and ChgA protein level in LNCaP cells after PCAT6 overexpression. (D) qPCR analysis of NSE, SYP, and ChgA mRNA expression in NCI-H660 cells after PCAT6 knockdown. (E) LNCaP cell proliferation was assayed using CCK-8 after PCAT6 overexpression. (F) NCI-H660 cell proliferation was assayed using CCK-8 after PCAT6 knockdown. (G, H) LNCaP cell invasion was assessed using transwell invasion assay after PCAT6 overexpression. (I, J) NCI-H660 cell invasion was assessed using transwell invasion assay after PCAT6 knockdown. * p <0.05. ** p <0.01.

Article Snippet: NE-like cells (PC3, DU145, and NCI-H660), LNCaP, C4-2 cells were purchased from ScienCell (Santiago, California, USA).

Techniques: In Vitro, Expressing, Over Expression, Western Blot, CCK-8 Assay, Transwell Invasion Assay

PCAT6 functioned as a ceRNA and sponged miR-326. (A) Starbase v2.0 database was used to predict potential miRNA binding sites in PCAT6. (B) qPCR analysis of miR-326 mRNA expression in NE-like cells (PC3, DU145, and NCI-H660) and LNCaP and C4-2 cells. (C) Schematic representation of the miR-326 site in PCAT6-3’UTR. (D) Luciferase activity was assayed in LNCaP cells co-transfected with miR-326 and luciferase reporters containing PCAT6-WT or PCAT6-Mut. Data are presented as the relative ratio of firefly luciferase activity to renilla luciferase activity. (E) Luciferase activity was assayed in LNCaP cells co-transfected with luciferase reporters containing PCAT6-WT and miR-326 or miR-326-Mut. (F) The direct binding of PCAT6 to miR-326 was affirmed using luciferase reporters in LNCaP cells treated with miR-326 or miR-326-mut. (G) qPCR analysis of miR-326 level in CRPC tissues (n=17) and NEPC tissues (n=9). ** p <0.01.

Journal: Frontiers in Oncology

Article Title: Enzalutamide-Induced Upregulation of PCAT6 Promotes Prostate Cancer Neuroendocrine Differentiation by Regulating miR-326/HNRNPA2B1 Axis

doi: 10.3389/fonc.2021.650054

Figure Lengend Snippet: PCAT6 functioned as a ceRNA and sponged miR-326. (A) Starbase v2.0 database was used to predict potential miRNA binding sites in PCAT6. (B) qPCR analysis of miR-326 mRNA expression in NE-like cells (PC3, DU145, and NCI-H660) and LNCaP and C4-2 cells. (C) Schematic representation of the miR-326 site in PCAT6-3’UTR. (D) Luciferase activity was assayed in LNCaP cells co-transfected with miR-326 and luciferase reporters containing PCAT6-WT or PCAT6-Mut. Data are presented as the relative ratio of firefly luciferase activity to renilla luciferase activity. (E) Luciferase activity was assayed in LNCaP cells co-transfected with luciferase reporters containing PCAT6-WT and miR-326 or miR-326-Mut. (F) The direct binding of PCAT6 to miR-326 was affirmed using luciferase reporters in LNCaP cells treated with miR-326 or miR-326-mut. (G) qPCR analysis of miR-326 level in CRPC tissues (n=17) and NEPC tissues (n=9). ** p <0.01.

Article Snippet: NE-like cells (PC3, DU145, and NCI-H660), LNCaP, C4-2 cells were purchased from ScienCell (Santiago, California, USA).

Techniques: Binding Assay, Expressing, Luciferase, Activity Assay, Transfection